News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Bryan, Garnier & Co Initiates Coverage of Hybrigenics with a Target Price of €2.6


3/29/2012 6:56:24 AM

PARIS--(BUSINESS WIRE)--Regulatory News:

Hybrigenics SA (ALHYG), a bio-pharmaceutical company listed on Alternext (NYSE-Euronext) in Paris, with a focus on research and development of new treatments against proliferative diseases, today announces the initiation of coverage of its stock by the investment bank Bryan, Garnier & Co with a target price of €2.6.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES